Agranulocytosis can leave patients vulnerable to severe infections, with early warning signs such as fever, sore throat and unexplained infections. "CDSCO's decision on for doxycycline and carbimazole reflects a proactive and responsible pharmacovigilance system. While the medicines remain safe and effective when used appropriately, clearer warnings help both doctors and patients recognise rare but important side effects early. Such regulatory steps strengthen patient safety without creating unnecessary alarm," he said.For patients, the updated leaflets will provide clearer information on potential risks. For clinicians, the advisory reinforces the need to counsel patients about warning symptoms and monitor use appropriately.

Source: Economic Times February 20, 2026 09:04 UTC